Is trametinib a targeted drug?

Trametinib is a targeted drug used alone or in combination with another drug called dabrafenib (Tafinlar) to treat certain types of cancer in people with the "BRAF" gene mutation. These drugs are used to treat: melanoma (skin cancer) that cannot be treated with surgery or has spread to other parts of the body (metastatic) or to prevent melanoma from coming back after surgery; metastatic non-small cell lung cancer or advanced or metastatic anaplastic thyroid cancer when there are no other treatment options.

Common side effects of trametinib include rectal bleeding or blood in the stool, bleeding gums, blemishes on the skin, blistering, crusting, inflammation, or reddening of the skin, swelling or swelling of the face, arms, hands, lower legs, or feet, nosebleeds, blurred vision, chest discomfort, pain or tight, cracked, dry, or scaly skin, coughing up blood, decreased urine output, diarrhea, difficulty moving, difficulty breathing or swallowing, dilated neck veins, extreme fatigue or weakness, fast, slow, irregular, or pounding heartbeat, headache, heavy or vaginal menstrual bleeding Tract bleeding, irregular breathing, joint pain, dizziness, dizziness, or unconsciousness, muscle aches, cramps, aches, or stiffness, nervousness, nosebleeds, numbness, pimples, deafness, prolonged bleeding from wounds, rapid weight gain, red or black cypress Oily stools, red or dark brown urine, red, swollen, or painful skin, scaling of the skin on the hands and feet, swelling of the hands, ankles, feet, or lower legs, numbness in the hands and feet, skin sores, unusual fatigue or weakness, unusual weight gain or loss, etc. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to learn more about high-quality overseas drugs for you.